http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101406314-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-00 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57438 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-11 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
filingDate | 2011-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2014-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2014-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101406314-B1 |
titleOfInvention | Novel Therapeutic Target for Pancreatic Cancer Based on Pancreatic Cancer Stem Cell Characteristics |
abstract | The present invention provides a method for screening a substance for preventing or treating pancreatic cancer using a novel molecular marker for pancreatic cancer stem cells and pancreatic cancer. The present invention provides a method for screening a substance for preventing or treating pancreatic cancer using a novel molecular marker for cancer stem cells and cancer. The pancreatic cancer or cancer therapeutic target of the present invention is very useful for screening candidates for therapeutic agents specifically acting on pancreatic cancer stem cells or cancer stem cells. Further, the present invention can accurately analyze the diagnosis and prognosis of pancreatic cancer or cancer. |
priorityDate | 2011-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 841.